 erythrocyt sediment rate predict relaps surviv early-stag hodgkin diseas eortc lymphoma cooper group object valu mm/h westergren erythrocyt sediment rate esr earli relaps surviv therapi patient clinic stage II hodgkin diseas intervent patient early-stag hodgkin diseas separ multicent clinic trial trial modern field radiotherapi patient multi-ag chemotherapi main result esr pattern pretherapi post-therapi assess pattern normal pattern therapi normal therapi pattern therapi normal month therapi pattern pattern normal therapi normal therapi pattern therapi normal therapi multivari analysi independ patient chemotherapi initi therapi protocol esr predictor earli relaps surviv patient type chemotherapi number involv nodal area patient esr pattern rel risk death time patient pattern earli relaps second import factor death irrespect esr patient earli relaps esr rel risk death earli relaps esr rel risk death chemotherapi rel risk esr initi therapi predictor earli relaps death due hodgkin diseas conclus unexplain esr therapi modern radiotherapi independ factor presenc aggress resist hodgkin diseas elev esr predict earli relaps poor prognosi presenc justifi aggress therapi